| MicroRNA-223-3p is a determinant of platelet procoagulant activity | Blood advances |  | | 2026 | 33 | 246 |
|
| The zebrafish model tackles anti-P2Y12 variability in humans : a translational approach | Blood advances | | | 2026 | 18 | 5 |
|
| miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa | Thrombosis and haemostasis | | | 2021 | 112 | 121 |
|
| Do miRNAs Have a Role in Platelet Function Regulation? | Hämostaseologie |  | | 2021 | 217 | 1 |
|
| An Ex Vivo and In Silico Study Providing Insights into the Interplay of Circulating miRNAs Level, Platelet Reactivity and Thrombin Generation: Looking beyond Traditional Pharmacogenetics | Journal of Personalized Medicine | | | 2021 | 261 | 324 |
|
| MicroRNA-126 is a regulator of platelet-supported thrombin generation | Platelets | | | 2020 | 322 | 424 |
|
| Methods to investigate miRNA function: focus on platelet reactivity | Thrombosis and Haemostasis | | | 2020 | 258 | 220 |
|
| Functional validation of microRNA-126-3p as a platelet reactivity regulator using human haematopoietic stem cells | Thrombosis and Haemostasis | | | 2019 | 524 | 541 |
|
| Human tissue-type plasminogen activator | Thrombosis and haemostasis | | | 2014 | 648 | 1,176 |
|
| Lack of association between connexin40 polymorphisms and coronary artery disease | Atherosclerosis | | | 2012 | 610 | 5 |
|
| Shear stress modulates the expression of the atheroprotective protein Cx37 in endothelial cells | Journal of Molecular and Cellular Cardiology | | | 2012 | 795 | 7 |
|
| Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells | Cardiovascular research | | | 2011 | 676 | 310 |
|
| Characterization of human late outgrowth endothelial progenitor-derived cells under various flow conditions | Journal of vascular research | | | 2011 | 581 | 1 |
|
| Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies | Blood | | | 2011 | 597 | 0 |
|
| Regulation of the endothelial plasminogen activator system by fluvastatin. Role of Rho family proteins, actin polymerisation and p38 MAP kinase | Thrombosis and haemostasis | | | 2011 | 636 | 452 |
|
| Ex vivo pulsatile perfusion of human saphenous veins induces intimal hyperplasia and increased levels of the plasminogen activator inhibitor 1 | European surgical research | | | 2010 | 711 | 520 |
|
| Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antiphospholipid syndrome | Haematologica | | | 2008 | 662 | 493 |
|
| Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques | Thrombosis and haemostasis | | | 2007 | 632 | 266 |
|
| Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues | Biochemical journal | | | 2007 | 653 | 398 |
|
| Gene conversion limits divergence of mammalian TLR1 and TLR6 | BMC evolutionary biology | | | 2007 | 623 | 378 |
|
| Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells | Stem cells |  | | 2006 | 630 | 0 |
|
| Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies | Thrombosis and haemostasis | | | 2005 | 726 | 520 |
|
| Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells | Thrombosis and haemostasis | | | 2001 | 112 | 0 |
|
